Deoxynucleotidyltransferase, terminal (DNTT) Peptid
Kurzübersicht für Deoxynucleotidyltransferase, terminal (DNTT) Peptid (ABIN938414)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- FQDLVVFILE KKMGTTRRAF LMELARRKGF RVENELSDSV THIVAENNSG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DNTT antibody,
Alternative Names: DNTT control peptide, DNTT antibody Blocking Peptide, Anti-DNTT Blocking Peptide, Deoxynucleotidyltransferase Terminal Blocking Peptide, TDT Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Hintergrund
- DNTT is a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, DNTT is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor geneegments.
-
Molekulargewicht
- 58 kDa
Target
-